Urinary Tract Dilations in Prenatal and Postnatal Life

Launched by SONOCLINIC · Mar 11, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on understanding urinary tract dilation, which is when the tubes that carry urine from the kidneys to the bladder are wider than normal. Researchers want to learn more about how doctors recognize and treat this condition in both unborn babies and newborns. They will gather information through surveys from medical professionals and track how these cases progress after birth. The goal is to develop better care plans for families dealing with urinary tract dilation.

To be eligible for this study, you would need to be a pregnant woman whose baby has been diagnosed with urinary tract dilation before the 28th week of pregnancy. Newborns and children who were diagnosed with this condition before birth and need to see a specialist in the first month after birth may also participate. Unfortunately, if there are multiple pregnancies, other serious conditions, or if the urinary dilation was discovered later in pregnancy, those cases cannot be included. Participants will likely be asked questions and monitored to help improve understanding and treatment of this condition, which could benefit many families in the future.

Gender

FEMALE

Eligibility criteria

• Inclusion criteria:
• • Singleton pregnant women whose fetuses were diagnosed with dilation of the urinary tract as an isolated US finding before the 28th week of pregnancy. Fetal patients with subsequent US control in the third trimester after the 28th week of pregnancy.
• • Newborns and children with prenatally diagnosed UTD, which, depending on the severity, required a postnatal examination by a pediatric nephrologist within a month after birth and then in his follow-up up to 6 months after birth.
• Exclusion criteria:
• • Multiple pregnancies
• • Urinary tract dilation in fetuses diagnosed in the third trimester
• • Associated anomalies in fetuses
• • Aneuploidy
• • Newborns and children monitored by someone other than a selected pediatric nephrologist Patients who were lost from follow-up